[1]
Wieteska, M., Kaczyńska, A., Maj, D., Stanicki, P., Chałupnik, A. and Wójcik, P. 2020. Metformin as a medicine decreasing cardiovascular risk in patients suffering from type 2 diabetes mellitus. Journal of Education, Health and Sport. 10, 8 (Aug. 2020), 105–111. DOI:https://doi.org/10.12775/JEHS.2020.10.08.012.